Financials data is unavailable for this security.
Cash flow in CNYView more
In 2023, cash reserves at Kintor Pharmaceutical Ltd fell by 420.44m. However, Cash Flow from Investing totalled 3.27m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 387.58m for operations while cash used for financing totalled 33.46m.
Cash flow per share | -2.31 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.963 |
---|---|
Tangible book value per share | 0.5965 |
More ▼
Balance sheet in CNYView more
Current ratio | 1.56 |
---|---|
Quick ratio | 1.56 |
Total debt/total equity | 0.6098 |
---|---|
Total debt/total capital | 0.3788 |
More ▼